FT

BioNTech fund pays €600m dividend on back of vaccine success

Photo of Financial Times Financial Times
0 Less than a minute

Munich-based MIG was founding investor in the German biotech, which lost €425m over past 11 years

Photo of Financial Times Financial Times
0 Less than a minute
Photo of Financial Times

Financial Times

Related Articles

Beijing gives green light for Hong Kong leg of Ant’s $30bn IPO

Coronavirus latest: France announces new nationwide lockdown to stop virus surge

Biden urged to keep patent protections for Covid vaccines

Hermès and Kering add to signs of luxury goods recovery

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button
WP2Social Auto Publish Powered By : XYZScripts.com